AlzeCure Pharma Cash Flow Reinvestment Rate

Latest as of March 2023: 0.00x

AlzeCure Pharma cash flow reinvestment rate. AlzeCure Pharma (ALZCUR) has a Cash Flow Reinvestment Rate of 0.00x as of March 2023, reinvesting Skr7.00K (capex Skr0.00 plus investments Skr7.00K) from operating cash flow of Skr28.09 Million. Explore ALZCUR cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

0.00x
(Capex + Investments) / Operating CF

Total Reinvested

Skr7.00K
Capex + Investments

Operating Cash Flow

Skr28.09 Million
SEK

Capital Expenditures

Skr0.00
SEK

Cash Flow Reinvestment Rate of AlzeCure Pharma (2023–2023)

Cash flow reinvestment rate of AlzeCure Pharma from 2023 to 2023. Historical reinvestment intensity for AlzeCure Pharma across 1 annual periods. Also explore ALZCUR net assets growth trend to track the company's year-over-year net asset growth rate.

AlzeCure Pharma Cash Flow Reinvestment Rate by Year (2023–2023)

AlzeCure Pharma cash flow reinvestment rate by year from 2023 to 2023. Year-by-year capital reinvestment analysis for AlzeCure Pharma. For the full cash flow conversion analysis, see ALZCUR operating cash flow.

Year Reinvestment Rate Total Reinvested (SEK) Operating CF Capex YoY Change
2023 0.00x Skr7.00K Skr3.06 Million Skr0.00 —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow